Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B.

@article{Hsu2014DeterminantsOH,
  title={Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B.},
  author={Yao-Chun Hsu and C Y Wu and Hsien-Yuan Lane and Chi-Yang Chang and Chi-Ming Tai and Cheng-Hao Tseng and G H Lo and Daw-Shyong Perng and Jaw-town Lin and L. P. Mo},
  journal={The Journal of antimicrobial chemotherapy},
  year={2014},
  volume={69 7},
  pages={
          1920-7
        }
}
OBJECTIVES We aimed to identify determinants of hepatocellular carcinoma (HCC) in cirrhotic patients who received nucleos(t)ide analogues for chronic hepatitis B (CHB). PATIENTS AND METHODS This retrospective-prospective study screened all patients (n = 1630) who received antiviral therapy for CHB between 1 September 2007 and 31 March 2013 at the E-Da Hospital and enrolled 210 consecutive cirrhotic patients with pretreatment viral DNA >2000 IU/mL. Those who developed HCC within 3 months of… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

Similar Papers

Loading similar papers…